Hutchmed - Business Information
Manufacturing · New Jersey, United States · 461 Employees
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capability. As of 2020, we have an in-house scientific team of around 680 professionals, and a pipeline of 10 clinical stage drug candidates in clinical studies around the world. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes prescription drugs and consumer health products, as well as two of our marketed novel oncology products ELUNATE® (fruquintinib capsules)and SULANDA® (surufatinib capsules) - in China. We are expanding the geographic scope of our commercial operations to include the U.S. and Europe.Read More
View Company Info for Free
Who is Hutchmed
Headquarters
Phone Number
Website
Revenue
Industry
Hutchmed Org Chart
Hutchmed Tech Stack
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Hutchmed News & Media
HUTCHMED (China) Limited (HCM) Q2 2023 Earnings Call Transcript
HUTCHMED (China) Limited (NASDAQ:NASDAQ:HCM) Q2 2023 Earnings Conference Call July 31, 2023 8:00 AM ETCompany ParticipantsMark Lee - SVP, Corporate Finance & DevelopmentWei-Guo Su -...HUTCHMED (China) (LON:HCM investor five-year losses grow to 53% as the stock sheds UK£125m this past week
We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...HUTCHMED (China) Limited (HCM) Q4 2022 Earnings Call Transcript
HUTCHMED (China) Limited (NASDAQ:NASDAQ:HCM) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ETCompany ParticipantsMark Lee - SVP Corporate Finance and Development Weiguo Su -...
Frequently Asked Questions regarding Hutchmed
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a full... Read More